The abstract is read at the publisher; the summary is JClub's.
A composite CT radiomic GTR-ITH score predicts treatment response and overall survival in 742 patients with unresectable HCC receiving first-line TACE-ICI-MTT, with OR 34.39 and HR 0.63.
- Why it matters: Intratumoral heterogeneity limits prediction of who benefits from TACE combined with immunotherapy and targeted therapy, creating a need for imaging biomarkers that capture both global and heterogeneity signals.
- What they did: Pretreatment CT radiomics quantified global tumor regions and intratumoral heterogeneity, then principal component analysis built a GTR-ITH score; ensemble machine learning predicted response and used AUC to assess performance.
- The result: The GTR-ITH score showed AUCs of 0.94 (training), 0.82 (internal validation), and 0.83 (independent test), and low-risk patients had longer progression-free and overall survival with an immune-inflamed pattern.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.